Williams' NESE Pipeline Faces New Challenge From Court Ruling

What happened

A court ruling has reversed a key water permit for Williams' NESE pipeline, adding another regulatory hurdle to the project. This development compounds existing challenges for Williams, which already faces high regulatory scrutiny and permitting delays across its system. In our latest deep-value assessment, we had rated WMB a potential sell due to an equity price ~73% above DCF-based intrinsic value and elevated leverage. The NESE setback could further impair growth expectations and delay cash flows from a fully contracted expansion, weakening the investment case. While Williams' core business remains stable with fee-based contracts, this incremental negative reinforces our cautious stance.

Implication

The court ruling on NESE's water permit introduces concrete project risk that was not fully reflected in our prior potential-sell thesis, and it increases the probability of delays or cancellation. This setback, combined with a stock trading at ~32x trailing EPS and ~15.7x EV/EBITDA, leaves little margin of safety. Elevated leverage (net debt/EBITDA ~4.1x) and thin interest coverage (~2.8x) further reduce the company's ability to absorb adverse outcomes. While Williams' fee-based contracts provide baseline stability, the loss of a major growth project undermines long-term earnings growth. We recommend existing holders use strength to reduce exposure and new investors remain on the sidelines until a more attractive risk-reward emerges, possibly below $50 per share.

Thesis delta

The NESE court ruling adds a concrete regulatory setback that was not fully priced into our previous potential-sell stance. While the core pipeline network remains durable, this event increases the likelihood of project delays or cancellation, eroding growth value. Consequently, we adjust our conviction from 'potential sell' to a clearer negative bias: investors should consider WMB overvalued given both the regulatory risk and existing premium multiples.